Triptolide suppresses human synoviocyte MH7A cells mobility and maintains redox balance by inhibiting autophagy
Triptolide (TPL), the main active ingredient in Tripterygium glycosides, has been reported to exert anti-inflammation and anti-tumor effects. The present study was designed to investigate the effects of TPL on rheumatoid arthritis (RA) and explore the underlying mechanisms. By using human synoviocyt...
Main Authors: | Chuanmei Xie, Jing Jiang, Jianping Liu, Guohua Yuan, Zhenyi Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218387067 |
Similar Items
-
Triptolide Induces Glioma Cell Autophagy and Apoptosis via Upregulating the ROS/JNK and Downregulating the Akt/mTOR Signaling Pathways
by: Xihong Liu, et al.
Published: (2019-05-01) -
Downregulation of miR-200a Protects Mouse Leydig Cells Against Triptolide by Triggering Autophagy
by: Miao H, et al.
Published: (2020-11-01) -
Triptolide Restores Autophagy to Alleviate Diabetic Renal Fibrosis through the miR-141-3p/PTEN/Akt/mTOR Pathway
by: Xiao-yu Li, et al.
Published: (2017-12-01) -
Triptolide Resistance Was Prevented by Metformin Co-Treatment Under Increased Growth Hormone Signaling Conditions in MDA-MB-231 Cells
by: Gizat Rakhmatula, et al.
Published: (2019-12-01) -
Identification of a binding target of triptolide and related studies
by: Zhao, Qian, et al.
Published: (2013)